• LAST PRICE
    279.1799
  • TODAY'S CHANGE (%)
    Trending Down-4.4301 (-1.5620%)
  • Bid / Lots
    279.0100/ 1
  • Ask / Lots
    279.1800/ 7
  • Open / Previous Close
    279.3800 / 283.6100
  • Day Range
    Low 276.5600
    High 281.3600
  • 52 Week Range
    Low 260.5200
    High 346.8500
  • Volume
    1,006,165
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 283.61
TimeVolumeAMGN
09:32 ET61836278.88
09:33 ET11712279.5647
09:35 ET5573280.54
09:37 ET12950280.585
09:39 ET6992280.02
09:42 ET5506279.05
09:44 ET4954279.36
09:46 ET4292278.993043
09:48 ET24077278.43
09:50 ET17367278.665
09:51 ET21585278.94
09:53 ET10727277.5464
09:55 ET8013278
09:57 ET4400277.67
10:00 ET18723276.8855
10:02 ET18222277.255
10:04 ET25404278.65
10:06 ET7371278.39
10:08 ET16431278.305
10:09 ET4849277.6
10:11 ET6424277.59
10:13 ET17804277.7
10:15 ET14033277.77
10:18 ET15263277.03
10:20 ET8006277.14
10:22 ET8197276.9
10:24 ET2718277.17
10:26 ET11409276.9058
10:27 ET8444276.8709
10:29 ET6587276.68
10:31 ET12108276.805
10:33 ET13307277.4
10:36 ET2790277.84
10:38 ET2715277.6653
10:40 ET4215277.09
10:42 ET4488277.725
10:44 ET3807277.92
10:45 ET10184277.535
10:47 ET3715277.96
10:49 ET1857277.9164
10:51 ET5881277.49
10:54 ET1940277.2785
10:56 ET3502276.93
10:58 ET5418277.03
11:00 ET4114277.434
11:02 ET5186277.89
11:03 ET5436278.33
11:05 ET5007277.93
11:07 ET2826278.01
11:09 ET5639278.25
11:12 ET4727278.53
11:14 ET1428278.69
11:16 ET9645278.57
11:18 ET7023278.15
11:20 ET1862277.91
11:21 ET8196278.065
11:23 ET4374278.57
11:25 ET7082278.79
11:27 ET3094278.94
11:30 ET2879279.085
11:32 ET6330279.225
11:34 ET4712279.22
11:36 ET12126279.22
11:38 ET6239278.97
11:39 ET519279.1799
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesAMGN
Amgen Inc
152.4B
35.7x
-0.22%
United StatesGILD
Gilead Sciences Inc
110.1B
1,051.5x
+1.53%
United StatesBMY
Bristol-Myers Squibb Co
114.0B
-15.7x
+4.90%
United StatesAZN
AstraZeneca PLC
195.9B
30.4x
+17.52%
United StatesSNY
Sanofi SA
122.0B
25.5x
+4.55%
United StatesHLN
Haleon PLC
42.0B
17.7x
---
As of 2024-11-18

Company Information

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and improve people's lives. It operates in human therapeutics segment. The Company’s marketed products portfolio includes Aranesp, ENBREL, Prolia (denosumab), Neulasta (pegfilgrastim), Otezla, XGEVA, Aranesp (darbepoetin alfa), KYPROLIS, Repatha (evolocumab), Nplate (romiplostim), Vectibix (panitumumab), MVASI (bevacizumab-awwb), Parsabiv (etelcalcetide), EPOGEN (epoetin alfa), KANJINTI (trastuzumab-anns), BLINCYTO (blinatumomab), Aimovig (erenumab-aooe), EVENITY (romosozumab-aqqg), AMGEVITATM (adalimumab), Sensipar/Mimpara (cinacalcet), NEUPOGEN (filgrastim), IMLYGIC (talimogene laherparepvec), Corlanor (ivabradine), KYPROLIS (carfilzomib), Maridebart cafraglutide, (infliximab-axxq), Evenity, LumaKras, Nplate and XGeva, others.

Contact Information

Headquarters
One Amgen Center DriveTHOUSAND OAKS, CA, United States 91320
Phone
805-447-1000
Fax
805-447-1010

Executives

Chairman of the Board, President, Chief Executive Officer
Robert Bradway
Chief Financial Officer, Executive Vice President
Peter Griffith
Executive Vice President, Chief Technology Officer
David Reese
Executive Vice President, Research and Development, and Chief Scientific Officer
James Bradner
Executive Vice President, General Counsel, Secretary
Jonathan Graham

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$152.4B
Revenue (TTM)
$32.5B
Shares Outstanding
537.5M
Dividend Yield
3.22%
Annual Dividend Rate
9.0000 USD
Ex-Dividend Date
11-18-24
Pay Date
12-09-24
Beta
0.57
EPS
$7.82
Book Value
$11.64
P/E Ratio
35.7x
Price/Sales (TTM)
4.7
Price/Cash Flow (TTM)
15.5x
Operating Margin
19.91%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.